Why the study?
Is there an association between hepatitis C virus (HCV) infection and hypertrophic cardiomyopathy?
Is there an association between hepatitis C virus (HCV) infection and hypertrophic cardiomyopathy?
Answers are grounded in this paper and cite their sources.
There is a significantly higher prevalence of HCV infection in patients with HCM, particularly the apical variant, suggesting a potential causal role in the pathogenesis of the disease.
The familial form of hypertrophic cardiomyopathy (HCM) is attributed to mutations in the genes for contractile proteins, but the etiology of non-familial form remains unknown. This study was designed to examine the clinical features, histopathologic changes, and hepatitis C virus (HCV) genomes in patients with HCM associated with HCV infection. Anti-HCV antibody was present in the sera of 9 of 65 patients (13.8%) with HCM versus 2.41% in a control population of voluntary blood donors in Japan, a statistically significant difference (p<0.0001). Among these 9 patients, 6 had ace-of-spades-shaped deformities of the left ventricle with apical hypertrophy. Myocardial fibrosis was found in all patients, and mild cellular infiltration was observed in 5 patients. Type 1b HCV RNA was present in the sera of 5 of the 9 patients. The copy number of HCV was 5.5x10(3)-8.6x10(5) genomes/ml serum, and multiple clones of HCV were detected in the sera of each patient by an analysis of the hypervariable regions using fluorescent single-strand conformation polymorphism. Positive strands of HCV were found in the hearts of 5 patients, and negative strands in the hearts of 2 patients. A high prevalence of HCV infection was found in patients with HCM, particularly of the apical variety, suggesting that HCV is an important causal agent in the pathogenesis of the disease.
No takes yet. Share an insight, caveat, or question.
Matsumori et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: